LUNAPHORE
Lunaphore Technologies S.A. is a Swiss company born with the vision of accelerating cancer research by bringing the field of spatial biology into mainstream laboratories. Lunaphore has developed its innovative spatial biology solutions based on an award-winning technology called FFeX (Fast Fluidic Exchange). Lunaphore has been recognized as one of the most innovative companies internationally.
LUNAPHORE
Industry:
Health Care Health Diagnostics Medical Device
Founded:
2014-01-01
Address:
Lausanne, Vaud, Switzerland
Country:
Switzerland
Website Url:
http://www.lunaphore.com
Total Employee:
51+
Status:
Active
Contact:
+41213535810
Email Addresses:
[email protected]
Total Funding:
38.77 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Wordpress Plugins
Similar Organizations
Dxcover
The Future of Cancer Diagnostics
Healthy.io
Healthy.io converts smartphone cameras into a clinical grade medical device.
Inito
Inito is the world’s first comprehensive at-home diagnostics device & App.
Injectsense
Monitoring therapy effectiveness (glaucoma) through miniaturized, autonomous in-vivo sensing and data uploading to cloud database.
iXensor
The pioneer of mobile health
Lia
Lia Diagnostics develops flush-able and eco-friendly pregnancy test.
ResApp Health
ResApp is developing digital healthcare solutions to assist doctors
Seno Medical Instruments
Seno Medical is commercialization efforts in opto-acoustic imaging of breast cancer.
Vamstar
GenAI-powered Global B2B Healthcare Marketplace
Current Advisors List
Current Employees Featured
Founder
Investors List
Swiss Entrepreneurs Foundation
Swiss Entrepreneurs Foundation investment in Series C - Lunaphore
Alpana Ventures
Alpana Ventures investment in Series C - Lunaphore
Redalpine
Redalpine investment in Series C - Lunaphore
OCCIDENT
OCCIDENT investment in Series C - Lunaphore
PHC Holdings
PHC Holdings investment in Series C - Lunaphore
Eurostars
Eurostars investment in Grant - Lunaphore
OCCIDENT
OCCIDENT investment in Series B - Lunaphore
Alpana Ventures
Alpana Ventures investment in Series B - Lunaphore
Zürcher Kantonal Bank
Zürcher Kantonal Bank investment in Series B - Lunaphore
OCCIDENT
OCCIDENT investment in Series A - Lunaphore
Official Site Inspections
http://www.lunaphore.com
- Host name: 104.21.35.99
- IP address: 104.21.35.99
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Lunaphore"
Lunaphore | Accelerating Spatial Biology | Multiplex Solutions
Lunaphore Technologies is a spatial biology company, building multiplex immunofluorescence & IHC solutions for discovery and immuno-oncology researchSee details»
Meet The Team | Lunaphore Technologies
Déborah leads the Lunaphore team and is responsible for setting strategy and growing the global Lunaphore business. Déborah co-founded Lunaphore in 2014 and has deep, cross-functional …See details»
About Lunaphore Technologies | Accelerating Spatial …
We are a team of innovators dedicated to empowering researchers and making spatial biology mainstream. We build solutions that simplify technology adoption for translational research laboratories who are developing better targeted …See details»
Lunaphore - Crunchbase Company Profile & Funding
Lunaphore is a life sciences company that is creating technologies to enable spatial biology in all laboratories. View contacts for Lunaphore to access new leads and connect with decision …See details»
Lunaphore Technologies SA - Swiss Biotech
Lunaphore has developed an innovative device for cancer tissue diagnostics. Its award-winning technology based on microfluidics aims to achieve faster & more precise results than current techniques. It was founded in 2004 with the vision …See details»
BIO-TECHNE TO ACQUIRE LUNAPHORE - Bio-Techne …
Jun 22, 2023 · Bio-Techne and Lunaphore recently announced a strategic partnership to develop the first fully automated spatial multiomic workflow.See details»
BIO-TECHNE TO ACQUIRE LUNAPHORE - PR Newswire
Jun 22, 2023 · Bio-Techne and Lunaphore recently announced a strategic partnership to develop the first fully automated spatial multiomic workflow.See details»
BIO-TECHNE COMPLETES LUNAPHORE ACQUISITION
Jul 10, 2023 · Bio-Techne and Lunaphore are combining forces to accelerate their spatial biology leadership position in translational and clinical research markets.See details»
Lunaphore Technologies: multiplex spatial biology …
Lunaphore’s game-changing chip technology is capable of visualizing up to forty markers in a single sample within one day, using off-the-shelf, label-free antibodies. Spatial biology studies the...See details»
COMETâ„¢ | Easy Multiplex Immunofluorescence
The Lunaphore COMETâ„¢ system has enabled us to perform highly-multiplexed imaging of entire cross sections of mouse hearts with sub-cellular resolution. The flexible panel design accelerated antibody validation and measurements so …See details»
LEADING RESEARCH INSTITUTES TO PRESENT NEW …
Oct 25, 2023 · Lunaphore's technology enables the identification of biomarker "signatures" with clinical relevance to support the development of diagnostic tools and streamline clinical trials, to ultimately improve patient outcomes. For …See details»
Lunaphore, an EPFL spin-off, brings its first product to market
Jul 2, 2019 · The first rapid screening test for cancer developed by EPFL spin-off Lunaphore is being released today. It holds the European Union's CE marking and will be available in most …See details»
EPFL spin-off Lunaphore raises 23 million francs
Lunaphore, a startup whose first product hit the European market in 2019, has announced that it has completed a new round of fundraising. The startup brought in 23 million francs in Series C, …See details»
Lunaphore announces acquisition by Bio-Techne, paving the way …
Jun 22, 2023 · Swiss life sciences company, Lunaphore Technologies SA, has announced its agreement to be acquired by Bio-Techne Corporation, a global leader in innovative tools for …See details»
LUNAPHORE COMET™ PLATFORM PAVES THE WAY FOR SPATIAL …
Nov 5, 2024 · Lunaphore provides solutions based on a game-changing chip technology that can extract spatial proteomic and transcriptomic data from tumors and other tissues, transforming …See details»
Lunaphore and CRO Sirona Dx collaborate to expand COMET™ …
Feb 23, 2023 · Lunaphore’s COMETâ„¢ platform is the only fully automated, high-throughput, hyperplex platform with superior tissue profiling capabilities. Its capacity allows the generation …See details»
Lunaphore raises CHF 40 million in Series D1 funding - BioAlps
Nov 12, 2024 · Lunaphore Technologies S.A is a Vaud-based spatial biology company, building multiplex immunofluorescence & IHC solutions for discovery and immuno-oncology research. …See details»
Lunaphore joins the Bio-Techne family - startupticker.ch
Jun 22, 2023 · Lunaphore is a leading developer of fully automated spatial biology solutions using precision microfluidic technology capable of revealing hyperplex proteomic and transcriptomic …See details»
Lunaphore continues U.S. expansion with completion of U.S. C ...
Jun 9, 2022 · Lunaphore has recruited industry veterans to bring its spatial biology technology and expertise to support a growing base of U.S. customers. Registration in the U.S. will enable …See details»
Lunaphore raises CHF40 million - startupticker.ch
Mar 23, 2023 · Lunaphore, a Swiss life sciences company developing technology to enable spatial biology in every laboratory, secured CHF40 million in the first close of Series D funding …See details»